automated-news
Sudeep Pharma IPO final day: GMP falls, issue gets strong subscription. Should you apply?
Sudeep Pharma’s Rs 895-crore IPO enters its final bidding day with strong overall demand, led by robust NII and retail participation. Despite a softening grey-market premium, subscription momentum remains healthy. Backed by diversified excipient capabilities,… Read Full Article →